Clinical Trials Logo

Idiopathic Pulmonary Fibrosis clinical trials

View clinical trials related to Idiopathic Pulmonary Fibrosis.

Filter by:

NCT ID: NCT03503188 Recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Digital Auscultation Test - IPF Data Collection

Start date: March 28, 2018
Phase: Phase 4
Study type: Interventional

The aim of this study is the data collection for patients with IPF and symptom matched controls to create a database of lung auscultation sounds and basic patient characteristics.

NCT ID: NCT03502902 Not yet recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

Start date: April 24, 2018
Phase: Phase 1
Study type: Interventional

A Phase I, Double-blind, Placebo-controlled, Single Oral Dose, Safety, Tolerability, and Pharmacokinetic Study, Incorporating an Evaluation of the Effect of Food on the Pharmacokinetics of HEC68498 in Healthy Male and Female Subjects

NCT ID: NCT03500731 Recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Start date: April 19, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether a lung transplantation prior to bone marrow transplantation (BMT) would allow for restoration of pulmonary function prior to BMT, allowing to proceed to BMT, to restore hematologic function.

NCT ID: NCT03499275 Not yet recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis

MUST-IPF
Start date: June 2018
Phase: N/A
Study type: Interventional

The aims of this study are to determine whether neuromuscular stimulation (NMES) of the quadriceps muscle is acceptable to patients with Idiopathic Pulmonary Fibrosis (IPF) and staff and whether it can impact clinical and healthcare resource usage outcomes.

NCT ID: NCT03486262 Enrolling by invitation - Clinical trials for Lung Cancer and Idiopathic Pulmonary Fibrosis

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

K-FPI
Start date: February 1, 2018
Phase:
Study type: Observational

Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.

NCT ID: NCT03480451 Recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis

IPF
Start date: September 12, 2017
Phase: N/A
Study type: Interventional

Idiopathic pulmonary fibrosis (IPF), a chronic fibrotic lung disease of unknown cause, is characterized by relentless progression, with a three-year mortality of up to 50%. IPF has high morbidity, with 90% of patients reporting dyspnea at the time of diagnosis and this is strongly correlated with quality of life and mortality. As IPF progress, breathlessness worsens, physical functional capacity declines, and health-related quality of life deteriorates. Pulmonary rehabilitation (PR) can improve well-being in patients with other chronic lung disease, but little is known regarding PR in IPF.

NCT ID: NCT03478553 Recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis (IPF)

Genetics of IPF - Screening Study for Family Members

Start date: January 18, 2018
Phase:
Study type: Observational

This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.

NCT ID: NCT03477526 Not yet recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis and COPD

Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation

Start date: August 2018
Phase: N/A
Study type: Interventional

As the result of our last study "Long Term effects of an Inpatient Pulmonary Program in Patients with Pulmonary Fibrosis" already demonstrated the positive effects of a Pulmonary Rehabiliation on the mental status. In this current study the aim will be to analyse the personality type regarding anxiety and depression

NCT ID: NCT03457935 Recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Detection of Early Idiopathic Pulmonary Fibrosis

Start date: April 10, 2018
Phase:
Study type: Observational

The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.

NCT ID: NCT03440489 Not yet recruiting - Clinical trials for Interstitial Lung Disease

Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary Fibrosis

Start date: July 2018
Phase: N/A
Study type: Interventional

Interstitial lung disease includes a heterogeneous group of chronic lung conditions that is characterized by exertional dyspnoea and poor health related quality of life . includes idiopathic pulmonary fibrosis of unknown cause And another groups are caused by occupational, inorganic or organic exposure, drug- induced toxicities, or are secondaries to connective tissue disease The clinical course and outcome of interstitial lung diseases are highly variable between different sub types, but survival after diagnosis of idiopathic pulmonary fibrosis is only 2.5 to 5 years is a progressive and fibrosing lung disease that is characterized by architectural distortion of the lung parenchyma and is progressive, with a dismal prognosis Also patient with idiopathic pulmonary fibrosis generally demonstrate greater abnormalities of exercise induced gas exchange than those with other forms of Interstitial lung disease